Literature DB >> 22464286

Elevated level of C-reactive protein is associated with risk of prediabetes in Indians.

Alok Jaiswal1, Rubina Tabassum, Avijit Podder, Saurabh Ghosh, Nikhil Tandon, Dwaipayan Bharadwaj.   

Abstract

BACKGROUND: Relationship of high sensitivity C-reactive protein (hsCRP) with prediabetes has not been explored extensively in Indians. Here we sought to investigate the association of hsCRP levels with prediabetes, as represented by impaired fasting glucose (IFG) and impaired glucose tolerance (IGT), and the influence of risk factors like obesity, decreased HDL cholesterol, hypertension, family history of diabetes and current smoking habit on the relationship.
METHODS: A cross-sectional study on 1726 Indians, comprising of 1276 individuals with normal glucose tolerance (NGT), 250 IFG and 200 IGT individuals. Subjects were defined according to WHO criteria based on fasting plasma and 2 h glucose levels.
RESULTS: Median levels of hsCRP were significantly higher in IFG (2.20 mg/l) and IGT (2.32 mg/l) compared to NGT (1.64 mg/l) subjects. Individuals with high risk hsCRP levels (>3 mg/l) had an odds ratio (OR) (95% confidence interval (CI)) of 2.60 (1.56-5.34) [P=1.3×10(-4)] for IGT after adjusting the effect of age, sex, medication, body mass index (BMI), waist circumference (WC) and risk factors like decreased high-density lipoprotein cholesterol (HDL-cholesterol), hypertension, family history of diabetes and current smoking. Significant increase in risk of IGT was found with a unit increase in natural log transformed hsCRP levels after adjustment for covariates [OR (95%CI)=1.57 (1.27-1.94), P=3.0×10(-5)]. When subjects were stratified on the basis of risk factors, we found stronger association of elevated hsCRP levels with risk of IFG and IGT in subjects having HDL-cholesterol ≤50 mg/dl and with hypertension.
CONCLUSIONS: Our study demonstrates that elevated hsCRP levels are independently associated with risk of IFG and IGT in Indians.
Copyright © 2012. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22464286     DOI: 10.1016/j.atherosclerosis.2012.02.034

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

1.  Serum C-reactive protein and metabolic components.

Authors:  Tomoyuki Kawada
Journal:  Endocrine       Date:  2013-04-26       Impact factor: 3.633

2.  Adiponectin and IL-6: Mediators of inflammation in progression of healthy to type 2 diabetes in Indian population.

Authors:  Smitha Upadhyaya; Vinitha Kadamkode; Rafi Mahammed; Chandraprabha Doraiswami; Gautam Banerjee
Journal:  Adipocyte       Date:  2013-10-08       Impact factor: 4.534

3.  Oxidized Low Density Lipoprotein and High Sensitive C-Reactive Protein in Non-Diabetic, Pre-Diabetic and Diabetic Patients in the Acute Phase of the First Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.

Authors:  Danijela Trifunović; Sanja Stanković; Jelena Marinković; Marko Banović; Nina Đukanović; Olga Vasović; Bosiljka Vujisić-Tešić; Milan Petrović; Jelena Stepanović; Ana Đorđević-Dikić; Branko Beleslin; Ivana Nedeljković; Milorad Tešić; Miodrag Ostojić
Journal:  J Med Biochem       Date:  2015-03-03       Impact factor: 3.402

Review 4.  High sensitivity C-reactive protein (hsCRP) & cardiovascular disease: An Indian perspective.

Authors:  Deepak Y Kamath; Denis Xavier; Alben Sigamani; Prem Pais
Journal:  Indian J Med Res       Date:  2015-09       Impact factor: 2.375

5.  Association of dietary patterns, anthropometric measurements, and metabolic parameters with C-reactive protein and neutrophil-to-lymphocyte ratio in middle-aged and older adults with metabolic syndrome in Taiwan: a cross-sectional study.

Authors:  Ahmad Syauqy; Chien-Yeh Hsu; Hsiao-Hsien Rau; Jane C-J Chao
Journal:  Nutr J       Date:  2018-11-19       Impact factor: 3.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.